Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs

Few medically-approved excipients are available for formulation strategies to endow microcarriers with improved performance in lung drug targeting. Konjac glucomannan (KGM) is a novel, biocompatible material, comprising mannose units potentially inducing macrophage uptake for the treatment of macrop...

Full description

Bibliographic Details
Main Author: Guerreiro, Filipa (author)
Other Authors: Swedrowska, Magda (author), Patel, Roshnee (author), Floréz- Fernández, Noelia (author), Torres, María Dolores (author), Rosa Da Costa, Ana M. (author), Forbes, Ben (author), Grenha, Ana (author)
Format: article
Language:eng
Published: 2022
Subjects:
Inhalation
Konjac glucomannan
Microparticles
Pulmonary drug delivery
Online Access:http://hdl.handle.net/10400.1/17805
Country:Portugal
Oai:oai:sapientia.ualg.pt:10400.1/17805

Internet

http://hdl.handle.net/10400.1/17805

Similar Items